Edwards Lifesciences’ prosthetic heart valve patent revoked by EPO
MLex Summary: The European Patent Office has revoked Edwards Lifesciences' patent for a prosthetic heart valve, following appeals by opponents Meril GmbH and Abbott Cardiovascular Systems. The patent was found to...To view the full article, register now.
Already a subscriber? Click here to view full article